NCT06600659View on ClinicalTrials.gov

A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Hematopoietic and Lymphatic System NeoplasmAcute Lymphobkastic Leukemia
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06600659 - A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase | Biotech Hunter | Biotech Hunter